ERCC1 and neoplasm: We recently showed that the presence of ERCC1+CTCs (circulating tumor cells) at primary diagnosis of ovarian cancer, a potentially platinum-resistant CTC-subgroup, is an independent predictive biomarker for primary platinum-resistance and poor prognosis of ovarian cancer [21].